Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human umbilical cord platelet-rich plasma
- Development stage
- Phase 2
- Lead developer
- Fundación IVI
- Modality
- Cell Therapies
- Administration
- Intrauterine
01
Overview
Human umbilical cord platelet-rich plasma (hUC-PRP) is an investigational biologic therapy developed by Fundación IVI in collaboration with the Instituto de Investigación Sanitaria La Fe. It consists of a concentrated preparation of platelets derived from human umbilical cord blood, which serves as a rich reservoir of pro-regenerative growth factors and anti-inflammatory molecules. The therapy is specifically designed to treat endometrial pathologies that cause infertility, such as Asherman syndrome, endometrial atrophy, and thin endometrium. By delivering high concentrations of factors like stem cell factor (SCF) and platelet-derived growth factor BB (PDGF-BB) directly into the sub-endometrial wall via hysteroscopic injection, hUC-PRP aims to stimulate tissue repair, promote angiogenesis, and restore the functional thickness of the endometrial lining.
- Other names
- umbilical cord blood-derived platelet-rich plasmaumbilical cord plasmahUC-PRP-Fundación IVI
Beyond the preview
Go deeper on human umbilical cord platelet-rich plasma.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human umbilical cord platelet-rich plasma.